ArticleCureus2026
Immediate and Sustained Resolution of Persistent Primary Monosymptomatic Enuresis Following Fascial Counterstrain Therapy: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary monosymptomatic enuresis (ME) that persists into adolescence presents significant physical and psychosocial challenges and is often resistant to conventional therapies. This case series describes three adolescents (aged 10, 12, and 15 years) with persistent, nightly ME who experienced immediate and sustained resolution of symptoms following Fascial Counterstrain (FCS) therapy. FCS is a multi-system manual therapy that applies an indirect osteopathic approach to restricted anatomical dysfunction and is well tolerated. In this study, FCS techniques associated with urogenital dysfunction were identified and treated in three adolescent cases. In each case, cessation of bedwetting occurred within 24 hours of the FCS session. Long-term follow-up at 10 to 24 months demonstrated continued resolution without the need for further treatment. These findings indicate that urogenital fascial restrictions may contribute to ME in some patients; however, further controlled research is required to validate these observations and explore the underlying physiological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.